Big Pharma Split (TSX:PRM) FCF Margin % : 311.35% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Big Pharma Split's Free Cash Flow for the six months ended in Dec. 2023 was C$1.29 Mil. Big Pharma Split's Revenue for the six months ended in Dec. 2023 was C$0.41 Mil. Therefore, Big Pharma Split's FCF Margin % for the quarter that ended in Dec. 2023 was 311.35%.

As of today, Big Pharma Split's current FCF Yield % is 72.70%.

The historical rank and industry rank for Big Pharma Split's FCF Margin % or its related term are showing as below:

TSX:PRM' s FCF Margin % Range Over the Past 10 Years
Min: -7605.41 Med: 30.4 Max: 3800.96
Current: 3800.96

During the past 7 years, the highest FCF Margin % of Big Pharma Split was 3800.96%. The lowest was -7605.41%. And the median was 30.40%.

TSX:PRM's FCF Margin % is ranked better than
99.16% of 1544 companies
in the Asset Management industry
Industry Median: 16.735 vs TSX:PRM: 3800.96

Big Pharma Split FCF Margin % Historical Data

The historical data trend for Big Pharma Split's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split FCF Margin % Chart

Big Pharma Split Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

245.10

738.20

-167.94

30.40

3,800.64

Big Pharma Split Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial								-87.83	4.34	102.12	-10,362.75	311.35

Competitive Comparison of Big Pharma Split's FCF Margin %

For the Asset Management subindustry, Big Pharma Split's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Big Pharma Split's FCF Margin % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's FCF Margin % falls into.

Big Pharma Split FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Big Pharma Split's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	11.858	/	0.312
	=	3,800.64 %

Big Pharma Split's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1.289	/	0.414
	=	311.35 %

Big Pharma Split FCF Margin % Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split (TSX:PRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

PRM.PR.A.PFD:Canada

Address

610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5

Website

https://www.harvestportfolios.com

Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Executives

Michael Kovacs

Director, Senior Officer